Steven Russell
Fortuna: 2 M $ al 31/05/2026
Fortuna: 2 M $ al 31/05/2026
Dr. Steven Russell is a Chief Medical Officer at Beta Bionics, Inc. and an Associate Professor at Harvard Medical School.
He received his undergraduate degree from Trinity University and a doctorate degree from The University of Texas Southwestern Medical Center.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BETA BIONICS, INC. 0,39 % | 02/06/2026 | 173.849 ( 0,39 % ) | 2 M $ | 31/05/2026 |
BETA BIONICS, INC. -.--% | 29/01/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BETA BIONICS, INC. | Director Técnico/Científico/I+D | 01/11/2022 |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Trinity University
Trinity University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.